Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3053% above fair value
$25.66−1.70 (-6.21%)
Close on Nov 17, 2026Market cap $1.92BP/E –Yield –
Schrodinger operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Schrodinger's operating cash flow for the twelve months ending Jun 30, 2026 was -$126.87M, down 561.4% year over year. For fiscal 2025 it was $13.90M. The highest annual figure on record is $16.76M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.90M | – |
| FY2024 | Dec 31, 2024 | -$157.37M | – |
| FY2023 | Dec 31, 2023 | -$136.73M | – |
| FY2022 | Dec 31, 2022 | -$119.68M | – |
| FY2021 | Dec 31, 2021 | -$70.67M | -521.7% |
| FY2020 | Dec 31, 2020 | $16.76M | – |
| FY2019 | Dec 31, 2019 | -$26.06M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.07M | – |
| Q1 FY2026 | Mar 31, 2026 | -$14.83M | -110.3% |
| Q4 FY2025 | Dec 31, 2025 | -$16.09M | – |
| Q3 FY2025 | Sep 30, 2025 | -$61.87M | – |
| Q2 FY2025 | Jun 30, 2025 | -$52.20M | – |
| Q1 FY2025 | Mar 31, 2025 | $144.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$31.11M | – |
| Q3 FY2024 | Sep 30, 2024 | -$33.26M | – |
| Q2 FY2024 | Jun 30, 2024 | -$53.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$39.28M | – |
| Q4 FY2023 | Dec 31, 2023 | -$37.26M | – |
| Q3 FY2023 | Sep 30, 2023 | -$49.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$18.44M | – |
| Q1 FY2023 | Mar 31, 2023 | -$31.09M | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.94M | – |
| Q3 FY2022 | Sep 30, 2022 | -$30.36M | – |
| Q2 FY2022 | Jun 30, 2022 | -$24.67M | – |
| Q1 FY2022 | Mar 31, 2022 | -$39.71M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.74M | -145.3% |
| Q3 FY2021 | Sep 30, 2021 | -$10.64M | – |
| Q2 FY2021 | Jun 30, 2021 | -$29.37M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.92M | – |
| Q4 FY2020 | Dec 31, 2020 | $43.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$12.03M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.05M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.78M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.27M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.93M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.24M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.62M | – |
See a number that looks wrong?